Jonathanc Fox News Today

Treatment-Related Early Increase in Serum TTR is Associated With Lower Cardiovascular Mortality in ATTR-CM: Insights From ATTRibute-CM Amrut...

Early Increase in Serum Transthyretin Level Is an Independent Predictor of Improved Survival in ATTR Cardiomyopathy: Insights From Acoramidis Phase 3 Study ATTRibute-CM ...

Higher Risk of Mortality in Previously Hospitalized Patients: Insights From ATTRibute-CM Ahmad Masri1, Michele Emdin2, Keyur Shah3, Kunal Bhatt4,...

Piper Sandler assumed coverage on shares of Edgewise Therapeutics (NASDAQ:EWTX – Free Report) in a research report report published on Thursday morning, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $48.00 price target on the stock. Separately, Wedbush dropped their target price on Edgewise Therapeutics from $27.00 to $23.00 and set an […]

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) – Equities researchers at Wedbush lifted their FY2023 earnings per share (EPS) estimates for shares of Edgewise Therapeutics in a report issued on Monday, January 22nd. Wedbush analyst L. Chico now expects that the company will earn ($1.50) per share for the year, up from their prior forecast […]

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) – Analysts at Wedbush issued their FY2028 earnings estimates for Edgewise Therapeutics in a research note issued to investors on Monday, January 22nd. Wedbush analyst L. Chico forecasts that the company will post earnings of $1.51 per share for the year. Wedbush currently has a “Outperform” rating and […]

Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) hit a new 52-week high during trading on Friday . The stock traded as high as $13.11 and last traded at $13.08, with a volume of 3033292 shares traded. The stock had previously closed at $9.69. Wall Street Analyst Weigh In Separately, Wedbush lowered their […]

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 8,500,000 shares, a growth of 20.9% from the November 30th total of 7,030,000 shares. Currently, 23.7% of the company’s shares are short sold. Based on an […]